Log inSign up
user avatar
Valneva
@valnevaSE
We are a specialty vaccine company that develops, manufactures and commercializes prophylactic vaccines for infectious diseases, addressing unmet medical needs.
Nantes, France
valneva.com
Joined December 2009
404
Following
7,954
Followers
  • user avatar
    Valneva
    @valnevaSE
    Oct 18, 2021
    Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Jan 19, 2022
    Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Nov 10, 2021
    Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million Doses of Inactivated COVID-19 Vaccine VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Oct 18, 2021
    Take a look at the positive results from the pivotal Phase 3 trial of Valneva’s inactivated, adjuvanted #COVID19 #vaccine candidate VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Dec 16, 2021
    Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Nov 23, 2021
    Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Nov 29, 2021
    Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Dec 23, 2021
    Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Apr 6, 2021
    Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Jan 6, 2022
    Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Apr 14, 2022
    Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Dec 8, 2021
    Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001 🇧🇭 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    Mar 1, 2022
    Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA2001 valneva.com/press-release/…
  • user avatar
    Valneva
    @valnevaSE
    May 16, 2022
    Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine valneva.com/press-release/…